193 related articles for article (PubMed ID: 15907820)
1. Interferon-gamma and atherosclerosis: pro- or anti-atherogenic?
Harvey EJ; Ramji DP
Cardiovasc Res; 2005 Jul; 67(1):11-20. PubMed ID: 15907820
[TBL] [Abstract][Full Text] [Related]
2. Interferon gamma: a master regulator of atherosclerosis.
McLaren JE; Ramji DP
Cytokine Growth Factor Rev; 2009 Apr; 20(2):125-35. PubMed ID: 19041276
[TBL] [Abstract][Full Text] [Related]
3. STAT1 as a novel therapeutical target in pro-atherogenic signal integration of IFNγ, TLR4 and IL-6 in vascular disease.
Sikorski K; Czerwoniec A; Bujnicki JM; Wesoly J; Bluyssen HA
Cytokine Growth Factor Rev; 2011 Aug; 22(4):211-9. PubMed ID: 21752694
[TBL] [Abstract][Full Text] [Related]
4. Gamma interferon: a central mediator in atherosclerosis.
Leon ML; Zuckerman SH
Inflamm Res; 2005 Oct; 54(10):395-411. PubMed ID: 16283107
[TBL] [Abstract][Full Text] [Related]
5. The two faces of the 15-lipoxygenase in atherosclerosis.
Wittwer J; Hersberger M
Prostaglandins Leukot Essent Fatty Acids; 2007 Aug; 77(2):67-77. PubMed ID: 17869078
[TBL] [Abstract][Full Text] [Related]
6. Interleukins in atherosclerosis: molecular pathways and therapeutic potential.
von der Thüsen JH; Kuiper J; van Berkel TJ; Biessen EA
Pharmacol Rev; 2003 Mar; 55(1):133-66. PubMed ID: 12615956
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of progression and stabilization of plaques by postnatal interferon-gamma function blocking in ApoE-knockout mice.
Koga M; Kai H; Yasukawa H; Yamamoto T; Kawai Y; Kato S; Kusaba K; Kai M; Egashira K; Kataoka Y; Imaizumi T
Circ Res; 2007 Aug; 101(4):348-56. PubMed ID: 17495225
[TBL] [Abstract][Full Text] [Related]
8. Pro- and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cells.
Yu J; Wei M; Becknell B; Trotta R; Liu S; Boyd Z; Jaung MS; Blaser BW; Sun J; Benson DM; Mao H; Yokohama A; Bhatt D; Shen L; Davuluri R; Weinstein M; Marcucci G; Caligiuri MA
Immunity; 2006 May; 24(5):575-90. PubMed ID: 16713975
[TBL] [Abstract][Full Text] [Related]
9. Hypercoagulability inhibits monocyte transendothelial migration through protease-activated receptor-1-, phospholipase-Cbeta-, phosphoinositide 3-kinase-, and nitric oxide-dependent signaling in monocytes and promotes plaque stability.
Seehaus S; Shahzad K; Kashif M; Vinnikov IA; Schiller M; Wang H; Madhusudhan T; Eckstein V; Bierhaus A; Bea F; Blessing E; Weiler H; Frommhold D; Nawroth PP; Isermann B
Circulation; 2009 Sep; 120(9):774-84. PubMed ID: 19687358
[TBL] [Abstract][Full Text] [Related]
10. Critical role for casein kinase 2 and phosphoinositide-3-kinase in the interferon-gamma-induced expression of monocyte chemoattractant protein-1 and other key genes implicated in atherosclerosis.
Harvey EJ; Li N; Ramji DP
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):806-12. PubMed ID: 17255531
[TBL] [Abstract][Full Text] [Related]
11. Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice.
Ait-Oufella H; Kinugawa K; Zoll J; Simon T; Boddaert J; Heeneman S; Blanc-Brude O; Barateau V; Potteaux S; Merval R; Esposito B; Teissier E; Daemen MJ; Lesèche G; Boulanger C; Tedgui A; Mallat Z
Circulation; 2007 Apr; 115(16):2168-77. PubMed ID: 17420351
[TBL] [Abstract][Full Text] [Related]
12. Interferon-gamma limits Th1 lymphocyte adhesion to inflamed endothelium: a nitric oxide regulatory feedback mechanism.
Norman MU; Zbytnuik L; Kubes P
Eur J Immunol; 2008 May; 38(5):1368-80. PubMed ID: 18412158
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta and atherosclerosis in man.
Grainger DJ
Cardiovasc Res; 2007 May; 74(2):213-22. PubMed ID: 17382916
[TBL] [Abstract][Full Text] [Related]
14. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets.
Schulz C; Schäfer A; Stolla M; Kerstan S; Lorenz M; von Brühl ML; Schiemann M; Bauersachs J; Gloe T; Busch DH; Gawaz M; Massberg S
Circulation; 2007 Aug; 116(7):764-73. PubMed ID: 17679613
[TBL] [Abstract][Full Text] [Related]
15. Postnatal blocking of interferon-gamma function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice.
Koga M; Kai H; Yasukawa H; Kato S; Yamamoto T; Kawai Y; Kusaba K; Seki Y; Kai M; Egashira K; Kataoka Y; Imaizumi T
Hypertens Res; 2007 Mar; 30(3):259-67. PubMed ID: 17510508
[TBL] [Abstract][Full Text] [Related]
16. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
[TBL] [Abstract][Full Text] [Related]
17. Interferon-γ in foam cell formation and progression of atherosclerosis.
Yu XH; Zhang J; Zheng XL; Yang YH; Tang CK
Clin Chim Acta; 2015 Feb; 441():33-43. PubMed ID: 25512166
[TBL] [Abstract][Full Text] [Related]
18. Fcgamma receptor deficiency confers protection against atherosclerosis in apolipoprotein E knockout mice.
Hernández-Vargas P; Ortiz-Muñoz G; López-Franco O; Suzuki Y; Gallego-Delgado J; Sanjuán G; Lázaro A; López-Parra V; Ortega L; Egido J; Gómez-Guerrero C
Circ Res; 2006 Nov; 99(11):1188-96. PubMed ID: 17053192
[TBL] [Abstract][Full Text] [Related]
19. Attenuated expression of profilin-1 confers protection from atherosclerosis in the LDL receptor null mouse.
Romeo GR; Moulton KS; Kazlauskas A
Circ Res; 2007 Aug; 101(4):357-67. PubMed ID: 17615372
[TBL] [Abstract][Full Text] [Related]
20. Inflammation and cellular immune responses in abdominal aortic aneurysms.
Shimizu K; Mitchell RN; Libby P
Arterioscler Thromb Vasc Biol; 2006 May; 26(5):987-94. PubMed ID: 16497993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
